SPARTAN-III Program (AAO)

 

Conscription
Like most Spartans, the Spartans of Epsilon company were conscripted at age six, and were taken to the planet of New Quebec to begin training in August 2555.

Training
Epsilon Company was trained rigorously, but instead of one instant procedure to give them their physical augmentations, these augmentations were applied by one procedure per year over a course of six years.

Epsilon company was trained by Ezekiel-254, a Class II Spartan II

Known Teams

 * Phoenix
 * Squad Leader: Wings-D339
 * Second in command: Zero-D576
 * Peec-D1074
 * Itzia-D102
 * X-D2552


 * Hawk Team
 * Squad Leader: D683
 * Second in command: Currently unknown
 * Unknown
 * Unknown
 * Unknown


 * Manticore team
 * Squad Leader: Unknown
 * Second in command: Unknown
 * Unknown
 * Unknown
 * Unknown


 * Flechette
 * Squad Leader: Unknown
 * Second in command: Unknown
 * Unknown
 * Unknown
 * Unknown


 * Dragoon
 * Squad Leader: Unknown
 * Second in command: Unknown
 * Unknown
 * Unknown
 * Unknown

Augmentations

 * 1) Carbide ceramic ossification: Advanced material: special metal and ceramic layers, grafting onto skeletal structure to make bones virtually unbreakable. Recommended coverage not to exceed 4 percent total bone mass because of significant white blood cell necrosis. Specific risk for pre- and near-post pubescent adolescents: skeletal growth spurts may cause irreparable bone pulverization.
 * 2) Muscular enhancement injections: Protein complex is injected intramuscular, to increase tissue density and decrease lactate recovery time. Risk: 1 percent of test subjects experience a fatal cardiac volume increase.
 * 3) Catalytic thyroid implant: Platinum pellet containing human growth hormone catalyst is implanted in the thyroid to boost growth of skeletal and muscle tissues. Risk: extremely rare instances of elephantiasis. Suppressed sexual drive.
 * 4) Occipital capillary reversal: Submergence and boosted blood vessel flow beneath the rods and cones of subject’s retina. Produces a marked visual perception increase. Risk: retinal rejection and detachment. Permanent blindness.
 * 5) Superconducting fabrication of neural dendrites: Alteration of bio-electrical nerve transduction to shielded electronic transduction. Three hundred sixty percent increase in subject’s reflexes. Anecdotal evidence of marked increase in intelligence, memory, and creativity. Risk: moderate instances of Parkinson’s disease and Fletcher’s syndrome.
 * 6) Increased Balance: Specialized superconducting of the VIIIth nerve's Vestibular Portion, which increases the person's sense of balance.  Risk: .5% chance of permanent disorientation due to nerve rejection.
 * 7) Boosted Immune System: Drug synthesizer bridged in to the aorta to boost the immune system and stimulate blood cell regeneration, improving resilience to disease and increasing cellular regeneration.  Risk: Rejection of the aortic artery.